Michael J. Brownstein
Corporate Officer/Principal presso Azevan Pharmaceuticals, Inc.
Profilo
Michael J.
Brownstein is currently the Vice President-Drug Development at Azevan Pharmaceuticals, Inc. He previously held positions as Co-Chairman at N-Gene Research Laboratories, Laboratory Chief & Scientific Director at National Institute of Mental Health, Chief Scientific Officer at Exponential Biotherapies, Genetics Laboratory Chief at National Institutes of Health, and Genetics Laboratory Chief at National Human Genome Research Institute.
Brownstein received his undergraduate degree from The Trustees of Columbia University in The City of New York and his doctorate from The University of Chicago and the University of Lund.
Posizioni attive di Michael J. Brownstein
Società | Posizione | Inizio |
---|---|---|
Azevan Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Corporate Officer/Principal | 15/12/2010 |
Precedenti posizioni note di Michael J. Brownstein
Società | Posizione | Fine |
---|---|---|
N-Gene Research Laboratories, Inc.
N-Gene Research Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services N-Gene Research Laboratories, Inc. operates as a clinical stage biopharmaceutical firm which focuses on developing a series of synthetic small molecules having a therapeutic effect via stress response modulation. Its products include oral anti-diabetic, skincare, and prokynetic. The company was founded by Peter Literati-Nagy in 1997 and is headquartered in New York, NY. | Presidente | - |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | - |
National Institute of Mental Health | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Michael J. Brownstein
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
The University of Chicago | Doctorate Degree |
University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Azevan Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Health Technology |
N-Gene Research Laboratories, Inc.
N-Gene Research Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services N-Gene Research Laboratories, Inc. operates as a clinical stage biopharmaceutical firm which focuses on developing a series of synthetic small molecules having a therapeutic effect via stress response modulation. Its products include oral anti-diabetic, skincare, and prokynetic. The company was founded by Peter Literati-Nagy in 1997 and is headquartered in New York, NY. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
National Institute of Mental Health | Government |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD. | Government |
- Borsa valori
- Insiders
- Michael J. Brownstein